These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 18559910)

  • 1. Longitudinal changes in insulin sensitivity and body composition of small-for-gestational-age adolescents after cessation of growth hormone treatment.
    Willemsen RH; Willemsen SP; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3449-54. PubMed ID: 18559910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of growth hormone treatment on metabolic and cardiovascular risk factors is similar in preterm and term short, small for gestational age children.
    de Kort SW; Willemsen RH; van der Kaay DC; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2009 Jul; 71(1):65-73. PubMed ID: 19094073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone mineral density and body composition in short children born SGA during growth hormone and gonadotropin releasing hormone analog treatment.
    Lem AJ; van der Kaay DC; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2013 Jan; 98(1):77-86. PubMed ID: 23125290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
    Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
    Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term impact of GH treatment during childhood on body composition and fat distribution in young adults born SGA.
    Breukhoven PE; Kerkhof GF; van Dijk M; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3710-6. PubMed ID: 21917862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic health of young adults who were born small for gestational age and treated with growth hormone, after cessation of growth hormone treatment: a 5-year longitudinal study.
    van der Steen M; Smeets CC; Kerkhof GF; Hokken-Koelega AC
    Lancet Diabetes Endocrinol; 2017 Feb; 5(2):106-116. PubMed ID: 28011067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Study on Metabolic Health in Adults SGA During 5 Years After GH With or Without 2 Years of GnRHa Treatment.
    Goedegebuure WJ; van der Steen M; Kerkhof GF; Hokken-Koelega ACS
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32436961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized GH trial with two different dosages in combination with a GnRH analogue in short small for gestational age children: effects on metabolic profile and serum GH, IGF1, and IGFBP3 levels.
    van der Kaay D; Bakker B; van der Hulst F; Mul D; Mulder J; Schroor E; van Elswijk D; Rowaan I; Willeboer M; de Ridder M; Hokken-Koelega A
    Eur J Endocrinol; 2010 May; 162(5):887-95. PubMed ID: 20176737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone-induced increases in skeletal muscle mass alleviates the associated insulin resistance in short children born small for gestational age, but not with growth hormone deficiency.
    Martin DD; Schweizer R; Schönau E; Binder G; Ranke MB
    Horm Res; 2009; 72(1):38-45. PubMed ID: 19571558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma matrix metalloproteinase-9 levels and blood pressure in short children born small for gestational age and effects of growth hormone treatment.
    Willemsen RH; van Dijk M; de Kort SW; van Toorenenbergen AW; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):264-8. PubMed ID: 18284641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle function improves during growth hormone therapy in short children born small for gestational age: results of a peripheral quantitative computed tomography study on body composition.
    Schweizer R; Martin DD; Schönau E; Ranke MB
    J Clin Endocrinol Metab; 2008 Aug; 93(8):2978-83. PubMed ID: 18505766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin Sensitivity and β-Cell Function in SGA Children Treated With GH and GnRHa: Results of a Long-Term Trial.
    van der Steen M; Lem AJ; van der Kaay DC; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2016 Feb; 101(2):705-13. PubMed ID: 26653111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin sensitivity modulates the growth response during the first year of high-dose growth hormone treatment in short prepubertal children born small for gestational age.
    Gies I; Thomas M; Tenoutasse S; De Waele K; Lebrethon MC; Beckers D; Francois I; Maes M; Rooman R; de Beaufort C; Massa G; De Schepper J
    Horm Res Paediatr; 2012; 78(1):24-30. PubMed ID: 22832126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First two years' response to growth hormone treatment in very young preterm small for gestational age children.
    Garcia RA; Longui CA; Kochi C; Arruda M; Faria CD; Calliari LE; Monte O; Pachi PR; Saenger P
    Horm Res; 2009; 72(5):275-80. PubMed ID: 19844113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid function in short children born small-for-gestational age (SGA) before and during GH treatment.
    de Kort SW; Willemsen RH; van der Kaay DC; van Dijk M; Visser TJ; Hokken-Koelega AC
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):318-22. PubMed ID: 18221400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth and growth hormone treatment in short stature children born small for gestational age.
    Labarta JI; Ruiz JA; Molina I; De Arriba A; Mayayo E; Longás AF
    Pediatr Endocrinol Rev; 2009 Feb; 6 Suppl 3():350-7. PubMed ID: 19404234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Height, muscle, fat and bone response to growth hormone in short children with very low birth weight born appropriate for gestational age and small for gestational age.
    Berndt C; Schweizer R; Ranke MB; Binder G; Martin DD
    Horm Res Paediatr; 2014; 82(2):81-8. PubMed ID: 24969628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
    Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for diabetes mellitus type 2 and metabolic syndrome are comparable for previously growth hormone-treated young adults born small for gestational age (sga) and untreated short SGA controls.
    van Dijk M; Bannink EM; van Pareren YK; Mulder PG; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2007 Jan; 92(1):160-5. PubMed ID: 17062774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.